SeaStar gets FDA approvable letter for use of SCD in paediatric patients
The SCD is a patented, cell-directed, extracorporeal device intended to be used as an additional therapy to lessen…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
31 Oct 23
The SCD is a patented, cell-directed, extracorporeal device intended to be used as an additional therapy to lessen…
27 Oct 23
Transforming the Landscape of Neuro-Oncology Diagnostics Through Non-Invasive Blood-Brain Barrier Opening
25 Oct 23
The MDR certificate encompasses all of RF Medical's product portfolios previously compliant with the MDD
24 Oct 23
VUNO Med-DeepBrain is designed to automate the existing manual process of detecting, labeling and quantifying segmentable brain structures…
24 Oct 23
The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods
20 Oct 23
DeepView SnapShot devices shipped to UK burn centers for evaluation
19 Oct 23
This is the third Breakthrough Device Designation granted by the FDA to SeaStar Medical for the SCD device,…
18 Oct 23
Trio of Clearances Expands VySpine’s Growing Product Portfolio
04 Oct 23
First-of-its-kind authorization provides potential marketing differentiation and opportunities for largest testing category
03 Oct 23
Developed in partnership with Mayo Clinic, ECG-AI LEF is an artificial intelligence-driven software-as-a-medical device to screen LEF using…